Literature DB >> 33973101

Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis.

Jingyue Zhang1,2,3, Yawen Song1,2,3, Qianqian Shi1,2,3, Li Fu4,5,6.   

Abstract

Tumorigenesis involves metabolic reprogramming and abnormal lipid metabolism, which is manifested by increased endogenous fat mobilization, hypertriglyceridemia, and increased fatty acid synthesis. Fatty acid synthase (FASN) is a key enzyme for the de novo synthesis of fatty acids, and monoacylglycerol esterase (MGLL) is an important metabolic enzyme that converts triglycerides into free fatty acids. Both enzymes play an important role in lipid metabolism and are associated with tumor-related signaling pathways, the most common of which is the PI3K-AKT signaling pathway. They can also regulate the immune microenvironment, participate in epithelial-mesenchymal transition, and then regulate tumor invasion and metastasis. Current literature have shown that these two genes are abnormally expressed in many types of tumors and are highly correlated with tumor migration and invasion. This article introduces the structures and functions of FASN and MGLL, their relationship with abnormal lipid metabolism, and the mechanism of the regulation of tumor invasion and metastasis and reviews the research progress of the relationship of FASN and MGLL with tumor invasion and metastasis.
© 2021. Higher Education Press.

Entities:  

Keywords:  FASN; MGLL; lipid metabolism; metastasis; tumor invasion

Mesh:

Substances:

Year:  2021        PMID: 33973101     DOI: 10.1007/s11684-021-0830-0

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  41 in total

1.  cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases.

Authors:  M Karlsson; J A Contreras; U Hellman; H Tornqvist; C Holm
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

2.  The "HER2-PI3K/Akt-FASN Axis" regulated malignant phenotype of colorectal cancer cells.

Authors:  Nan Li; Xiaodong Bu; Peng Wu; Pingping Wu; Peilin Huang
Journal:  Lipids       Date:  2012-01-06       Impact factor: 1.880

3.  Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene.

Authors:  M Karlsson; K Reue; Y R Xia; A J Lusis; D Langin; H Tornqvist; C Holm
Journal:  Gene       Date:  2001-07-11       Impact factor: 3.688

4.  Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.

Authors:  Zongxian Cao; Melinda M Mulvihill; Partha Mukhopadhyay; Huan Xu; Katalin Erdélyi; Enkui Hao; Eileen Holovac; György Haskó; Benjamin F Cravatt; Daniel K Nomura; Pál Pacher
Journal:  Gastroenterology       Date:  2013-01-04       Impact factor: 22.682

5.  MicroRNA-544 attenuates diabetic renal injury via suppressing glomerulosclerosis and inflammation by targeting FASN.

Authors:  Tao Sun; Yang Liu; Lingyun Liu; Fuzhe Ma
Journal:  Gene       Date:  2019-07-16       Impact factor: 3.688

6.  Fatty acid synthesis configures the plasma membrane for inflammation in diabetes.

Authors:  Xiaochao Wei; Haowei Song; Li Yin; Michael G Rizzo; Rohini Sidhu; Douglas F Covey; Daniel S Ory; Clay F Semenkovich
Journal:  Nature       Date:  2016-11-02       Impact factor: 49.962

7.  Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.

Authors:  Yasi Mo; Yong Wu; Xin Li; Hui Rao; Xianxiang Tian; Danni Wu; Zhenpeng Qiu; Guohua Zheng; Junjie Hu
Journal:  Eur J Pharmacol       Date:  2019-11-08       Impact factor: 4.432

8.  Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.

Authors:  Li-Hsuan Huang; Hsin-Yun Chung; Hui-Min Su
Journal:  BMC Cancer       Date:  2017-12-28       Impact factor: 4.430

9.  Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.

Authors:  Ligong Chang; Surong Fang; Yubao Chen; Zhenhua Yang; Yuan Yuan; Jing Zhang; Liang Ye; Wei Gu
Journal:  Lipids Health Dis       Date:  2019-05-24       Impact factor: 3.876

10.  Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders.

Authors:  Ming Jiang; Mario van der Stelt
Journal:  J Med Chem       Date:  2018-10-11       Impact factor: 7.446

View more
  6 in total

Review 1.  CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.

Authors:  Roozbeh Moghaddar; Amirhossein Fakhre Yaseri; Sadegh Shojaei Baghini; Zhanna R Gardanova; Saeme Azizi Hassan Abadi; Burhan Abdullah Zaman; Ahmet İlhan; Navid Shomali; Ali Adili
Journal:  Cell Mol Biol Lett       Date:  2022-05-04       Impact factor: 8.702

2.  Association between fatty acid synthase and adipophilin expression in triple-negative breast cancer.

Authors:  Katsuhiro Yoshikawa; Mitsuaki Ishida; Hirotsugu Yanai; Koji Tsuta; Mitsugu Sekimoto; Tomoharu Sugie
Journal:  Mol Clin Oncol       Date:  2022-02-09

3.  A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value.

Authors:  Ding Li; Jiaming Liang; Wei Yang; Wenbin Guo; Wenping Song; Wenzhou Zhang; Xuan Wu; Baoxia He
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

Review 4.  Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review.

Authors:  Meng-Ying Cui; Xing Yi; Zhen-Zhen Cao; Dan-Xia Zhu; Jun Wu
Journal:  J Oncol       Date:  2022-09-05       Impact factor: 4.501

5.  Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer.

Authors:  Zihan Zhao; Ning Jiang; Yulin Zhang; Yuhao Bai; Tianyao Liu; Tianhang Li; Hongqian Guo; Rong Yang
Journal:  Front Genet       Date:  2022-09-29       Impact factor: 4.772

6.  Integrated Analyses Identify Key Molecules and Reveal the Potential Mechanism of miR-182-5p/FOXO1 Axis in Alcoholic Liver Disease.

Authors:  Zhihua Zuo; Yiqin Li; Chuyi Zeng; Yuge Xi; Hualin Tao; Yongcan Guo
Journal:  Front Med (Lausanne)       Date:  2021-12-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.